Interim report
Page 1
Note : This document has been translated from the Japanese original for reference purposes only . In the event of any discrepancy between this translated document and the Japanese original , the original shall prevail . August 6 , 2026 Company name : Consolidated Financial Results for the Three Months Ended June 30 , 2026 ( Under Japanese GAAP ) SHIMADZU CORPORATION Tokyo Stock Exchange https://www.shimadzu.co.jp Listing : Securities code : 7701 URL : Representative : Inquiries : Telephone : Yasunori Yamamoto , President and Representative Director Hiroshi Ogasawara , General Manager , Finance and Accounting Dept. + 81-75-823-1127 Scheduled date to commence dividend payments : Preparation of supplementary material on financial results : Holding of financial results briefing : Yes Yes ( for institutional investors and analysts ) ( Yen amounts are rounded down to millions , unless otherwise noted . ) 1. Consolidated financial results for the three months ended June 30 , 2026 ( from April 1 , 2026 to June 30 , 2026 ) ( 1 ) Consolidated operating results ( cumulative ) ( Percentages indicate year - on - year changes . ) Profit attributable to Net sales Operating profit Ordinary profit owners of parent Three months ended Millions of yen % Millions of yen % Millions of yen % Millions of yen % June 30 , 2026 June 30 , 2025 130,596 118,370 10.3 1.2 14,264 12,184 17.1 18,486 11.2 11,323 63.3 ( 17.3 ) 13,333 68.3 7,921 ( 20.7 ) Note : Comprehensive income For the three months ended June 30 , 2026 : For the three months ended June 30 , 2025 : ¥ 21,140 million ¥ 7,268 million [ 190.8 % ] [ ( 60.5 ) % ] Basic earnings per share Diluted earnings per share Three months ended Yen Yen June 30 , 2026 46.14 June 30 , 2025 27.42 Reference : Operating profit before amortization of goodwill For the three months ended June 30 , 2026 : For the three months ended June 30 , 2025 : ¥ 14,638 million ¥ 12,537 million [ 16.8 % ] [ 11.9 % ] The Company uses operating profit before amortization of goodwill as an important management indicator . ( 2 ) Consolidated financial position Total assets Net assets Equity - to - asset ratio As of Millions of yen Millions of yen % June 30 , 2026 March 31 , 2026 730,470 737,978 575,162 565,166 78.7 76.6 Reference : Equity As of June 30 , 2026 : As of March 31 , 2026 : ¥ 575,152 million ¥ 565,156 million
Page 2
2. Cash dividends Annual dividends per share First quarter-end Second quarter-end Third quarter-end Fiscal year-end Total Yen Yen Yen Yen Yen Fiscal year ended March 31, 2026 – 27.00 – 42.00 69.00 Fiscal year ending March 31, 2027 – Fiscal year ending March 31, 2027 (Forecast) 27.00 – 43.00 70.00 Note: Revisions to the forecast of cash dividends most recently announced: None 3. Consolidated earnings forecast for the fiscal year ending March 31, 2027 (April 1, 2026 to March 31, 2027) (Percentages indicate year-on-year changes.) Net sales Operating profit Ordinary profit Profit attributable to owners of parent Basic earnings per share Millions of yen % Millions of yen % Millions of yen % Millions of yen % Yen Fiscal year ending March 31, 2027 620,000 10.6 80,000 8.5 81,000 (2.1) 59,000 (2.5) 204.19 Note: Revisions to the earnings forecast most recently announced: Yes * For matters related to the above forecast, please refer to page 7, “(3) Consolidated Outlook” in “1. Operating Results.” Reference: Operating profit before amortization of goodwill ¥85,000 million [13.1%]
Page 3
* Notes (1) Significant changes in the scope of consolidation during the period: None Newly included: – companies (–) Excluded: – companies (–) (2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: None (3) Changes in accounting policies, changes in accounting estimates, and restatement (i) Changes in accounting policies due to revisions to accounting standards and other regulations: None (ii) Changes in accounting policies due to other reasons: None (iii) Changes in accounting estimates: None (iv) Restatement: None (4) Number of issued shares (common shares) (i) Total number of issued shares at the end of the period (including treasury shares) As of June 30, 2026 296,070,227 shares As of March 31, 2026 296,070,227 shares (ii) Number of treasury shares at the end of the period As of June 30, 2026 7,130,100 shares As of March 31, 2026 7,130,002 shares (iii) Average number of shares outstanding during the period Three months ended June 30, 2026 288,940,165 shares Three months ended June 30, 2025 288,918,676 shares * Review of the Japanese-language originals of the attached quarterly consolidated financial statements by certified public accountants or an audit firm: None * Proper use of earnings forecasts, and other special matters 1. The consolidated earnings forecast for the fiscal year ending March 31, 2027 that was announced on May 12, 2026 has been revised in this document. 2. The above forecast was calculated based on information available on the date this report was released. Actual results may vary from forecast values, due to various factors in the future. For matters related to the above forecast, please refer to page 7, “(3) Consolidated Outlook” in “1. Operating Results.”
Page 4
SHIMADZU CORPORATION (7701) - 1 - Table of Contents Index 1. Operating Results ...................................................................................................................................... 2 (1) Overview of Operating Results for the Period ................................................................................... 2 (2) Overview of Financial Status for the Period ...................................................................................... 7 (3) Consolidated Outlook ......................................................................................................................... 7 2. Quarterly Consolidated Financial Statements and Significant Notes ....................................................... 8 (1) Quarterly Consolidated Balance Sheets ............................................................................................. 8 (2) Quarterly Consolidated Statement of Income and Quarterly Consolidated Statement of Comprehensive Income .................................................................................................................... 10 (3) Notes on Quarterly Consolidated Financial Statements ................................................................... 12 Notes on Segment Information, Etc. ................................................................................................ 12 Notes on the Event of Significant Fluctuations in Shareholders’ Capital ......................................... 14 Notes on Going-Concern Assumptions ............................................................................................ 14 Notes on Quarterly Consolidated Statement of Cash Flows ............................................................ 14 Notes on Events After the Reporting Period .................................................................................... 15 3. Supplemental Information ...................................................................................................................... 17
Page 5
SHIMADZU CORPORATION (7701) - 2 - 1. Operating Results (1) Overview of Operating Results for the Period During the three months ended June 30, 2026, the global economy remained generally resilient, but uncertainty about the future persisted due to economic sluggishness in the Chinese economy and the normalization of geopolitical risks, such as the prolonged conflict in Ukraine and escalating tensions in the Middle East. On the other hand, the semiconductor-related market was buoyant, and there was also active investment in the pharmaceutical market related to research, development, and production of biopharmaceuticals. Under these circumstances, the Group focused on expanding its core businesses*, which are emphasized in the Medium-Term Management Plan that began in FY2026. Specifically, we deployed liquid chromatograph systems and mass spectrometer systems to meet the research, development, quality control, and labor-saving needs of the pharmaceutical and food markets. We also advanced our recurring business by strengthening our lineup of reagents and consumables and expanding our service business. Additionally, aiming for growth in growing markets, particularly the semiconductor market, we worked on enhancing sales of turbomolecular pumps, the main products of our Industrial Machinery segment, and expanding service bases to grow our recurring business. Given the above, Shimadzu posted net sales for the three months ended June 30, 2026 of 130,596 million yen (a year-on-year increase of 10.3%), reflecting the positive impact of currency exchange due to the depreciation of the yen, setting a new record high. Operating profit was 14,264 million yen (a year-on-year increase of 17.1%). Ordinary profit was 18,486 million yen (a year-on-year increase of 63.3%), and profit attributable to owners of parent was 13,333 million yen (a year-on-year increase of 68.3%). Operating profit before amortization of goodwill was 14,638 million yen. *Note: Core business: Liquid chromatograph systems, mass spectrometer systems, gas chromatograph systems, and recurring business The results for reportable business segments were as follows. For the three months ended June 30, 2026, the Group changed its important management indicator from operating profit to operating profit before amortization of goodwill. Accordingly, segment profit represents operating profit before amortization of goodwill for each segment in the following section.
Page 6
SHIMADZU CORPORATION (7701) - 3 - I. Analytical & Measuring Instruments In the Analytical & Measuring Instruments segment, we strengthened sales in growth areas such as the clinical testing, government, and university markets in Europe, and the pharmaceutical market in China. We focused on the active launch of new products and the strengthening of solution proposal capabilities. Additionally, by expanding our lineup and building value chain partnerships, we enhanced after-sales services, reagents, and consumables, and worked to expand the recurring business. These efforts led to an increase in liquid chromatograph systems for the pharmaceutical and clinical testing markets in the life science field. By region, although sales in other Asian countries decreased due to sales delays in India caused by the situation in the Middle East, sales increased in Japan, Europe and North America, resulting in an overall increase. As a result, the Analytical & Measuring Instruments segment posted net sales of 80,300 million yen (a year-on-year increase of 6.0%), supported by the positive impact of foreign exchange rates. Segment profit increased owing to our value-added strategy, but decreased to 7,668 million yen (a year-on-year decrease of 15.2%) due to sales delays caused by the Middle East situation and higher material costs. Net sales broken down by major regions are indicated below. Consolidated Results for Three Months of FY 2025 (millions of yen) Consolidated Results for Three Months of FY 2026 (millions of yen) Percent Increase/ Decrease (%) Overview Japan 24,084 25,080 4.1 Sales of liquid chromatograph systems increased for the pharmaceutical market, and testing machines increased for the electronics and machinery sectors. Outside Japan 51,704 55,219 6.8 The overseas sales ratio was 68.8%, up 0.6 pt. Major regions North America 9,232 10,264 11.2 Sales of liquid chromatograph systems increased for universities. Europe 9,291 11,392 22.6 Sales of mass spectrometer systems increased for clinical testing companies, the government sector, and universities. China 16,660 17,008 2.1 Sales of liquid chromatograph systems increased for biopharmaceuticals. Other Asian countries 12,056 11,285 (6.4) In India, sales of mass spectrometer systems decreased due to sales delays caused by the situation in the Middle East.
Page 7
SHIMADZU CORPORATION (7701) - 4 - II. Medical Systems In the Medical Systems segment, we implemented market penetration strategies for distinctive new products that integrate AI and IoT technologies for image analysis. We also pursued initiatives to improve profitability, including enhancing gross profit through value propositions and reducing sales of less profitable products. As a result of these efforts, sales of general radiography systems, X-ray TV systems, and angiography systems all increased. By region, although net sales in Japan decreased due to a reduction in the handling of less profitable products, net sales increased significantly overseas due to the effects of new products. As a result, the Medical Systems segment posted net sales of 16,907 million yen (a year-on-year increase of 23.5%), and segment profit was 1,114 million yen, compared to a segment loss of 716 million yen in the same period of the previous year, due to increased sales and improved profitability. Net sales broken down by major regions are indicated below. Consolidated Results for Three Months of FY 2025 (millions of yen) Consolidated Results for Three Months of FY 2026 (millions of yen) Percent Increase/ Decrease (%) Overview Japan 7,043 6,783 (3.7) Although sales of X-ray systems, particularly general radiography systems and X-ray TV systems, increased, sales decreased due to a reduction in the handling less profitable products. Outside Japan 6,648 10,123 52.3 The overseas sales ratio was 59.9%, up 11.3 pt. Major regions North America 2,306 3,263 41.5 Sales of general radiography systems and mobile X-ray systems increased due to the effect of new products. Europe 367 988 169.0 Sales of general radiography systems and mobile X-ray systems increased due to the effect of new products. China 859 1,397 62.7 Sales of general radiography systems and X-ray TV systems increased by capturing demand from government-promoted economic measures. Other Asian countries 1,442 2,077 44.0 In Southeast Asia, a focus area, sales of angiography systems increased.
Page 8
SHIMADZU CORPORATION (7701) - 5 - III. Industrial Machinery In the Industrial Machinery segment, driven by the expanding demand for advanced semiconductor devices led by generative AI, sales of turbomolecular pumps for semiconductor manufacturing equipment remained strong, and sales in the recurring business also increased. Sales of hydraulic equipment increased, particularly for industrial vehicles and construction machinery. By region, sales increased in all major regions, both in Japan and overseas. As a result, the Industrial Machinery segment posted net sales of 20,734 million yen (a year-on-year increase of 23.2%), and segment profit was 3,823 million yen (a year-on-year increase of 43.5%) due to the increase in net sales. Net sales broken down by major regions are indicated below. Consolidated Results for Three Months of FY 2025 (millions of yen) Consolidated Results for Three Months of FY 2026 (millions of yen) Percent Increase/ Decrease (%) Overview Japan 6,019 7,319 21.6 Sales of turbomolecular pumps for use in semiconductor manufacturing equipment significantly increased, and sales of hydraulic equipment for construction machinery increased. Outside Japan 10,813 13,415 24.1 The overseas sales ratio was 64.7%, up 0.5 pt. Major regions North America 1,857 2,565 38.1 Sales of turbomolecular pumps for use in semiconductor manufacturing equipment significantly increased. Europe 1,034 1,281 23.9 Sales of turbomolecular pumps for use in semiconductor manufacturing equipment significantly increased. China 5,671 5,827 2.8 Although sales of turbomolecular pumps for coating equipment decreased, sales of hydraulic equipment for industrial vehicles and agricultural machinery increased. Other Asian countries 2,217 3,706 67.1 Sales of turbomolecular pumps for use in semiconductor manufacturing equipment and related services significantly increased in Taiwan and South Korea.
Page 9
SHIMADZU CORPORATION (7701) - 6 - IV . Aircraft Equipment In the Aircraft Equipment segment, we developed operations by capturing the growing demand for equipment for defense and commercial aircraft. In Japan, sales for the defense field significantly increased due to the government’s policy of reinforcing defense capabilities. Overseas, due to the rise in air passenger demand, the commercial aircraft field saw an expansion in demand for aircraft equipment for aircraft manufacturer, as well as an increase in demand for spare parts for airline companies driven by special demand. As a result, the Aircraft Equipment segment posted net sales of 11,031 million yen (a year-on-year increase of 11.4%), and segment profit of 2,745 million yen (a year-on-year increase of 33.9%) due to the increase in net sales and profitability improvement. Net sales broken down by major regions are indicated below. Consolidated Results for Three Months of FY 2025 (millions of yen) Consolidated Results for Three Months of FY 2026 (millions of yen) Percent Increase/ Decrease (%) Overview Japan 7,713 8,585 11.3 In the defense field, sales of aircraft equipment increased due to the government’s policy of reinforcing defense capabilities. Outside Japan 2,186 2,446 11.9 The overseas sales ratio was 22.2%, up 0.1 pt. Major regions North America 1,908 2,019 5.8 Sales increased due to the expanded demand for equipment for commercial aircraft and spare parts for airline companies. V . Other Other business segments posted net sales of 1,621 million yen (a year-on-year decrease of 24.8%) and segment profit of 149 million yen (a year-on-year decrease of 37.7%).
Page 10
SHIMADZU CORPORATION (7701) - 7 - (2) Overview of Financial Status for the Period As of June 30, 2026, while investment securities increased by 13,088 million yen and inventories increased by 7,982 million yen compared to the end of the previous year, notes and accounts receivable - trade, and contract assets decreased by 18,921 million yen and cash and deposits decreased by 13,683 million yen. Consequently, total assets decreased by 7,507 million yen to 730,470 million yen. Liabilities decreased by 17,503 million yen to 155,307 million yen, reflecting decreases of 10,649 million yen in income taxes payable and 8,178 million yen in provision for bonuses. Net assets increased by 9,996 million yen to 575,162 million yen, reflecting increases of 6,565 million yen in valuation difference on available-for-sale securities and 2,148 million yen in retained earnings. (3) Consolidated Outlook The future outlook is expected to remain uncertain due to the normalization of geopolitical risks, such as increasing tensions in the Middle East, global monetary policy trends, and other factors impacting the economy. Under this business environment, the Group will continue to actively invest in its core businesses and strive to improve its performance. Regarding the consolidated earnings forecast, after comprehensively considering the view that the booming semiconductor-related market continues, among other factors, a more limited impact on demand from the Middle East situation than initially anticipated, the continued depreciation of the yen, and the contribution to business performance from the consolidation of Tescan Group a.s. which the Group acquired in July 2026, the Group has decided to upwardly revise the earnings forecast announced on May 12, 2026. Operating profit before amortization of goodwill is expected to be 85,000 million yen. (Millions of yen) Previous Forecast (A) Revised Forecast (B) Increase/ Decrease (B-A) Percent Increase/ Decrease (%) (Reference) Results for the Previous Fiscal Year Net Sales 575,000 620,000 45,000 10.6 560,728 Operating Profit 76,000 80,000 4,000 8.5 73,702 Ordinary Profit 75,000 81,000 6,000 (2.1) 82,753 Profit Attributable to Owners of Parent 55,000 59,000 4,000 (2.5) 60,499 Note: The forecasted results above were calculated based on information available on the date this report was released. Actual results may vary from forecast values, due to various factors in the future.
Page 11
SHIMADZU CORPORATION (7701) - 8 - 2. Quarterly Consolidated Financial Statements and Significant Notes (1) Quarterly Consolidated Balance Sheets (Millions of yen) As of March 31, 2026 As of June 30, 2026 Assets Current assets Cash and deposits 167,316 153,632 Notes and accounts receivable - trade, and contract assets 156,326 137,405 Merchandise and finished goods 86,449 90,673 Work in process 29,458 32,352 Raw materials and supplies 36,191 37,055 Other 23,895 28,566 Allowance for doubtful accounts (1,909) (1,923) Total current assets 497,728 477,762 Non-current assets Property, plant and equipment Buildings and structures, net 56,016 55,726 Machinery, equipment and vehicles, net 12,245 12,247 Land 22,181 22,219 Leased assets, net 1,678 1,654 Construction in progress 2,592 4,231 Other, net 28,100 28,264 Total property, plant and equipment 122,815 124,345 Intangible assets Goodwill 7,388 7,230 Other 16,497 16,826 Total intangible assets 23,886 24,056 Investments and other assets Investment securities 20,357 33,445 Long-term loans receivable 225 301 Retirement benefit asset 54,422 54,996 Deferred tax assets 10,964 5,858 Other 7,625 9,751 Allowance for doubtful accounts (48) (48) Total investments and other assets 93,546 104,305 Total non-current assets 240,249 252,707 Total assets 737,978 730,470
Page 12
SHIMADZU CORPORATION (7701) - 9 - (Millions of yen) As of March 31, 2026 As of June 30, 2026 Liabilities Current liabilities Notes and accounts payable - trade 41,532 36,660 Lease liabilities 4,033 3,963 Accounts payable - other 18,905 17,282 Income taxes payable 15,015 4,366 Contract liabilities 41,250 44,827 Provision for bonuses 14,841 6,663 Provision for bonuses for directors (and other officers) 384 92 Provision for share awards 119 40 Provision for recall 772 700 Other 13,392 17,240 Total current liabilities 150,248 131,836 Non-current liabilities Lease liabilities 6,450 6,457 Provision for retirement benefits for directors (and other officers) 139 128 Retirement benefit liability 13,810 14,683 Provision for share awards – 11 Other 2,164 2,189 Total non-current liabilities 22,563 23,470 Total liabilities 172,811 155,307 Net assets Shareholders’ equity Share capital 26,648 26,648 Capital surplus 34,910 34,910 Retained earnings 452,619 454,767 Treasury shares (26,070) (26,030) Total shareholders’ equity 488,108 490,297 Accumulated other comprehensive income Valuation difference on available-for-sale securities 8,163 14,729 Foreign currency translation adjustment 43,402 45,215 Remeasurements of defined benefit plans 25,482 24,911 Total accumulated other comprehensive income 77,048 84,855 Non-controlling interests 9 9 Total net assets 565,166 575,162 Total liabilities and net assets 737,978 730,470
Page 13
SHIMADZU CORPORATION (7701) - 10 - (2) Quarterly Consolidated Statement of Income and Quarterly Consolidated Statement of Comprehensive Income Quarterly Consolidated Statement of Income (Millions of yen) Three months ended June 30, 2025 Three months ended June 30, 2026 Net sales 118,370 130,596 Cost of sales 65,116 70,335 Gross profit 53,253 60,260 Selling, general and administrative expenses 41,069 45,996 Operating profit 12,184 14,264 Non-operating income Interest income 339 418 Dividend income 176 265 Insurance claim income 26 25 Subsidy income 40 183 Foreign exchange gains – 3,378 Other 230 263 Total non-operating income 813 4,534 Non-operating expenses Interest expenses 65 59 Donations 15 22 Foreign exchange losses 1,256 – Share of loss of entities accounted for using equity method 48 65 Other 289 164 Total non-operating expenses 1,674 312 Ordinary profit 11,323 18,486 Extraordinary income Gain on sale of non-current assets 6 20 Total extraordinary income 6 20 Extraordinary losses Loss on disposal of non-current assets 36 14 Total extraordinary losses 36 14 Profit before income taxes 11,293 18,491 Income taxes - current 1,432 2,766 Income taxes - deferred 1,940 2,391 Total income taxes 3,372 5,158 Profit 7,921 13,332 Loss attributable to non-controlling interests (0) (0) Profit attributable to owners of parent 7,921 13,333
Page 14
SHIMADZU CORPORATION (7701) - 11 - Quarterly Consolidated Statement of Comprehensive Income (Millions of yen) Three months ended June 30, 2025 Three months ended June 30, 2026 Profit 7,921 13,332 Other comprehensive income Valuation difference on available-for-sale securities 547 6,565 Foreign currency translation adjustment (877) 1,812 Remeasurements of defined benefit plans, net of tax (323) (571) Total other comprehensive income (652) 7,807 Comprehensive income 7,268 21,140 Comprehensive income attributable to Comprehensive income attributable to owners of parent 7,268 21,140 Comprehensive income attributable to non-controlling interests (0) 0
Page 15
SHIMADZU CORPORATION (7701) - 12 - (3) Notes on Quarterly Consolidated Financial Statements Notes on Segment Information, Etc. 1) Segment Information I From April 1 to June 30 of fiscal year ended March 31, 2026 Information on net sales and profit (loss) by reportable segment (Millions of yen) Reportable segment Other (Note 1) Subtotal Adjust- ments (Note 2) Total (Note 3) Analytical & Measuring Instruments Medical Systems Industrial Machinery Aircraft Equipment Total for Reportable segment Net sales Sales to customers 75,789 13,692 16,833 9,899 116,215 2,155 118,370 – 118,370 Inter-segment sales 7 6 6 6 27 561 588 (588) – Total 75,797 13,698 16,840 9,906 116,242 2,717 118,959 (588) 118,370 Operating profit (loss) 9,040 (716) 2,664 2,050 13,038 239 13,277 (740) 12,537 Notes: 1. The “Other” category is a business segment that is not included in the reportable segments. It includes businesses such as real estate rental, real estate management, and construction flooring. 2. An adjustment to segment operating profit (loss) of (740) million yen consists primarily of testing and research expenses and core system-related expenses that are not allocated to the reportable segments. 3. The difference between the total amount of segment operating profit (loss) shown in the table above and the operating profit of 12,184 million yen recorded in the consolidated statement of income is due to a 352 million yen amortization of goodwill, etc. This goodwill, etc., includes intangible assets acquired as identifiable assets on the date of business combination.
Page 16
SHIMADZU CORPORATION (7701) - 13 - II From April 1 to June 30 of fiscal year ending March 31, 2027 1. Information on net sales and profit (loss) by reportable segment (Millions of yen) Reportable segment Other (Note 1) Subtotal Adjust- ments (Note 2) Total (Note 3) Analytical & Measuring Instruments Medical Systems Industrial Machinery Aircraft Equipment Total for Reportable segment Net sales Sales to customers 80,300 16,907 20,734 11,031 128,974 1,621 130,596 – 130,596 Inter-segment sales 25 6 20 – 52 610 663 (663) – Total 80,325 16,913 20,755 11,031 129,027 2,232 131,259 (663) 130,596 Operating profit 7,668 1,114 3,823 2,745 15,352 149 15,501 (862) 14,638 Notes: 1. The “Other” category is a business segment that is not included in the reportable segments. It includes businesses such as real estate rental, real estate management, and construction flooring. 2. An adjustment to segment operating profit of (862) million yen consists primarily of testing and research expenses and core system-related expenses that are not allocated to the reportable segments. 3. The difference between the total amount of segment operating profit shown in the table above and the operating profit of 14,264 million yen recorded in the consolidated statement of income is due to a 374 million yen amortization of goodwill, etc. This goodwill, etc., includes intangible assets acquired as identifiable assets on the date of business combination. 2. Changes in Reportable Segments Starting from the period from April 1 to June 30 of fiscal year ending March 31, 2027, the Group has switched from using operating profit to operating profit before amortization of goodwill as an important management indicator, and the method for measuring segment profit has been changed to reflect this change. This change was made to measure the results of continuous earning power in our main business. The segment information for the period from April 1 to June 30 of fiscal year ending March 31, 2026 has also been adjusted in line with these changes. As a result of these changes, segment operating profit (loss) has increased by 292 million yen in the Analytical & Measuring Instruments segment, 42 million yen in the Medical Systems segment, and 18 million yen in the Industrial Machinery segment, and the total has increased by 352 million yen.
Page 17
SHIMADZU CORPORATION (7701) - 14 - 2) Related Information Information on the Amount of Net Sales by Geographical Segment From April 1 to June 30 of fiscal year ended March 31, 2026 (Millions of yen) Japan The Americas Europe China Other Asian countries Other Total 47,015 18,000 10,884 23,236 15,751 3,482 118,370 From April 1 to June 30 of fiscal year ending March 31, 2027 (Millions of yen) Japan The Americas Europe China Other Asian countries Other Total 49,390 21,432 13,989 24,242 17,159 4,381 130,596 Note: Main countries and regions included in the geographical segments other than Japan The Americas: U.S.A. Europe: U.K., Germany China: China Other Asian countries: India, Southeast Asia, South Korea, Taiwan Other: Australia, Middle East, Africa Notes on the Event of Significant Fluctuations in Shareholders’ Capital Not applicable. Notes on Going-Concern Assumptions Not applicable. Notes on Quarterly Consolidated Statement of Cash Flows The Company has not prepared a quarterly consolidated statement of cash flows for the three months ended June 30, 2026. Amounts of depreciation (including amortization of intangible assets excluding goodwill) and amortization of goodwill are as follows. (Millions of yen) Three months ended June 30, 2025 Three months ended June 30, 2026 Depreciation 5,015 5,249 Amortization of goodwill 212 229
Page 18
SHIMADZU CORPORATION (7701) - 15 - Notes on Events After the Reporting Period [Business Combination by Acquisition] At the Board of Directors’ meeting held on December 25, 2025, the Company resolved to acquire Tescan Group a.s. (“Tescan”), one of the pioneering companies in electron microscopy based in Europe, through a share purchase of all the shares of Glass HoldCo s.r.o., a special purpose company indirectly holding all the shares in Tescan. The Company also concluded a stock transfer agreement on December 25, 2025, and acquired the shares on July 10, 2026. 1. Outline of the business combination (1) Name of acquired company and its business outline Name of the acquired company: Glass HoldCo s.r.o. Business outline: Administrative services and services of an organizational and economic nature Name of the acquired company: Tescan Group a.s. Business outline: Manufacturing and sales of analytical and measuring instruments centered on electron microscopy (2) Main reason for business combination Tescan is recognized as one of the pioneering companies in electron microscopy, which is expected to see significant growth within analytical and measurement instruments market. Its products are highly regarded for their robustness and user friendliness, with a proven track record of more than 4,000 units sold across 80 countries worldwide, including regions such as North America, Europe, and Asia, serving applications in materials science, semiconductors, and life sciences. In addition to Scanning Electron Microscopes (“SEM”) and Focused Ion Beam SEM (“FIB SEM”), Tescan also handles precision measurement instruments such as Transmission Electron Microscope (“TEM”), and Micro CT systems. The Company believes that Tescan’s “surface observation and analysis” capabilities complement the Company’s “composition analysis” and “physical property analysis,” and will significantly contribute to enhancing the Company’s growth potential and profitability. (3) Date of business combination July 10, 2026 (4) Legal form of business combination Share acquisition (5) Name of company after combination No change. (6) Ratio of voting rights acquired 100.0% (7) Basis for determining the acquirer It is based on the fact that the Company acquired 100% of voting rights by means of share acquisition in consideration for cash. 2. Acquisition cost of the acquired company and related details of each class of consideration Consideration for acquisition Cash 711 million U.S. dollars (115,342 million yen) Assumption of the seller’s liabilities 40 million U.S. dollars (6,492 million yen) Acquisition cost 751 million U.S. dollars (121,835 million yen) The above amounts are the consideration at the time of acquisition. Final amounts may differ from the above due to price adjustments.
Page 19
SHIMADZU CORPORATION (7701) - 16 - 3. Major acquisition-related costs To be determined. 4. Amount of goodwill incurred, reasons for the goodwill incurred, and the method and period of amortization To be determined. 5. The assets acquired and the liabilities assumed at the acquisition date To be determined. [Large Borrowing] The Company borrowed the following amount on July 1, 2026, for the purpose of allocating funds necessary for the acquisition of shares of Tescan: (1) Lender: MUFG Bank, Ltd. (2) Aggregate amount of borrowings: 110,000 million yen (3) Interest rates: Market interest rate plus spread (4) Drawdown date: July 1, 2026 (5) Collateral/guarantee: None Refinancing of the borrowings into medium- to long term funds is under consideration.
Page 20
SHIMADZU CORPORATION (7701) - 17 - 3. Supplemental Information Overview of Financial Results for the First Three Months of the Fiscal Year Ending March 2027 Row No. Consolidated Results for First Three Months of FY 2025 Consolidated Results for First Three Months of FY 2026 Year on Year FY 2025 FY 2026 Results Results Increase/Decr ease Percent Increase/ Decrease Results Forecast 1 Net Sales millions of yen 118,370 130,596 12,225 10.3% 560,728 620,000 2 Net Sales (Analytical & Measuring Instruments) millions of yen 75,789 80,300 4,510 6.0% 364,908 – 3 Net Sales (Medical Systems) millions of yen 13,692 16,907 3,215 23.5% 73,794 – 4 Net Sales (Industrial Machinery) millions of yen 16,833 20,734 3,901 23.2% 71,523 – 5 Net Sales (Aircraft Equipment) millions of yen 9,899 11,031 1,131 11.4% 43,371 – 6 Net Sales (Other) millions of yen 2,155 1,621 (533) (24.8)% 7,130 – 7 Net Sales by Region (Japan) millions of yen 47,015 49,390 2,374 5.1% 242,581 – 8 Net Sales by Region (Outside Japan) millions of yen 71,355 81,205 9,850 13.8% 318,147 – 9 Net Sales (The Americas) millions of yen 18,000 21,432 3,432 19.1% 81,866 – 10 Net Sales (Europe) millions of yen 10,884 13,989 3,104 28.5% 54,802 – 11 Net Sales (China) millions of yen 23,236 24,242 1,006 4.3% 91,736 – 12 Net Sales (Other Asian Countries) millions of yen 15,751 17,159 1,407 8.9% 71,468 – 13 Net Sales (Other) millions of yen 3,482 4,381 899 25.8% 18,272 – 14 Operating Profit millions of yen 12,184 14,264 2,079 17.1% 73,702 80,000 15 Operating Profit before Amortization of Goodwill millions of yen 12,537 14,638 2,101 16.8% 75,142 85,000 16 Ordinary Profit millions of yen 11,323 18,486 7,162 63.3% 82,753 81,000 17 Profit Attributable to Owners of Parent millions of yen 7,921 13,333 5,411 68.3% 60,499 59,000 18 Earnings per Share (FY 2026 Q1) Yen 27.42 46.14 – – 209.39 204.19 19 Dividend per Share Yen – – – – 69.00 70.00 20 Capital Equipment Investment millions of yen 5,360 7,845 2,485 46.4% 22,117 30,000 21 Depreciation and Amortization millions of yen 5,015 5,249 233 4.7% 20,381 20,000 22 Total Assets millions of yen 647,299 730,470 83,170 12.8% 737,978 – 23 Net Assets millions of yen 493,549 575,162 81,612 16.5% 565,166 – 24 Equity-to-Asset Ratio % 76.2 78.7 – – 76.6 – 25 Number of All Group Employees Employees 14,753 14,885 132 – 14,649 – 26 Number of Consolidated Subsidiaries Companies 78 75 – – 77 –
Page 21
SHIMADZU CORPORATION (7701) - 18 - Row No. Consolidated Results for First Three Months of FY 2025 Consolidated Results for First Three Months of FY 2026 Year on Year FY 2025 FY 2026 Results Results Increase/Decr ease Percent Increase/ Decrease Results Forecast 27 Japan Companies 21 21 – – 21 – 28 Outside Japan Companies 57 54 – – 56 –